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A B S T R A C T
A 67-year-old woman with exertional dyspnea was referred to our hospital. Transthoracic
echocardiography revealed severe mitral regurgitation and signiﬁcant left ventricular (LV) outﬂow
tract obstruction due to prominent systolic anterior motion (SAM) of the mitral valve without LV
hypertrophy. Oral bisoprolol remarkably attenuated SAM. Two- or three-dimensional echocardiographic
analysis demonstrated the elongation of anterior and posterior mitral leaﬂets and interventricular
septum (IVS) bulging due to narrow aorto-mitral angle. In the present case, elongation of mitral leaﬂet
and hyperkinetic motion of left ventricle, and IVS bulging due to narrow aorto-mitral angle possibly play
important roles in the development of SAM.
<Learning objective: Mitral regurgitation due to systolic anterior motion (SAM) can be dramatically
improved by beta-blocker therapy. Although the precise mechanism of SAM has not been fully
elucidated, structural changes of mitral apparatus (elongation of mitral leaﬂet and papillary muscle
displacement), and structural or functional features of left ventricle (hyperkinetic motion, small
ventricle, interventricular septum bulging, narrow aorto-mitral angle) possibly play important roles in
the development of SAM.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Systolic anterior motion (SAM) of the mitral valve was ﬁrst
reported as a feature of hypertrophic cardiomyopathy (HCM), and
it had previously been considered as a speciﬁc ﬁnding to HCM
[1]. However, SAM may be detected in the absence of left
ventricular outﬂow tract (LVOT) obstruction, and even seen
without typical echocardiographic ﬁndings of HCM. It has been
shown that SAM can be experimentally produced by the
administration of dobutamine in normal dogs with a high success
rate [2]. A possible role of structural changes of mitral valve during* Corresponding author at: Department of Cardiovascular Medicine, Kobe City
Medical Center General Hospital, 2-1-1, Minatojima-minamimachi, Chuo-ku, Kobe
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1878-5409/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightthe development of SAM has also been reported such as leaﬂet
elongation and papillary muscle displacement [3–6]. Herein, we
present a clinical case of severe mitral regurgitation (MR) and SAM,
which was dramatically attenuated by beta-blocker therapy. The
ﬁndings in this case seem to be informative with respect to the
mechanisms of SAM and consequent MR.
Case report
A 67-year-old woman was referred to our hospital due to a 2-
month history of dyspnea on mild exertion. Physical examination
and laboratory test revealed no obvious triggers for left ventricular
(LV) hyperkinetic motion such as infection, dehydration, anemia,
and hyperthyroidism. The 12-lead electrocardiogram results were
normal. Transthoracic echocardiography revealed severe mitral
regurgitation and signiﬁcant LV outﬂow tract obstruction (peaks reserved.
Fig. 1.
Two-dimensional transthoracic echocardiography and color ﬂow imaging before initiation of a beta-blocker. (a) Apical long-axis view. Prominent systolic
anterior motion of the mitral valve with septal contact can be seen, and the mitral leaﬂets bended at the mid-portion, resulting in loss of coaptation. Left
ventricular wall motion is hyperkinetic, and there is no concentric or asymmetric left ventricular hypertrophy. (b) Color ﬂow imaging shows severe mitral
regurgitation with the jet directed posteriorly, and signiﬁcant left ventricular outﬂow tract obstruction (peak velocity was 5.8 m/s).
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(SAM) of the mitral valve without LV hypertrophy. LV wall motion
was hyperkinetic, with an ejection fraction of 74%, and interven-
tricular septum (IVS) bulging due to narrow aorto-mitral angle was
observed. Anterior mitral leaﬂet bended at its mid-portion,
resulting in loss of coaptation (Fig. 1a and b; Additional movie
ﬁles show this in more detail (see Additional ﬁles 1 and 2)].
Four days after the initiation of bisoprolol treatment (2.5 mg
daily), the LV wall motion was normalized, and SAM of the mitral
leaﬂet was signiﬁcantly reduced. IVS bulging due to narrow aortic
mitral angle was still observed, but MR and LVOT obstruction
almost completely disappeared (Fig. 2a and b, and Additional ﬁles
3–5). Measurement of the mitral leaﬂet lengths using three-
dimensional reconstruction by transesophageal echocardiography
indicated elongation of the leaﬂets with an anterior leaﬂet length
of 2.2 cm and a posterior leaﬂet length of 1.7 cm, respectively
(normal ranges, 1.8  0.3 cm for anterior leaﬂet, 1.1  0.2 cm for
posterior leaﬂet [4]). The narrowest LVOT diameter during systole
was 1.4 cm (see Additional ﬁle 5). Cardiac magnetic resonance
imaging revealed no structural abnormalities including displacement
of papillary muscles. Bisoprolol was increased to 5 mg daily, and wasFig. 2.
Two-dimensional transthoracic echocardiography and color ﬂow imaging after
systolic anterior motion of the mitral leaﬂet was signiﬁcantly reduced. (b) Colo
completely disappeared.well tolerated by her. After that, she has never complained of dyspnea
on exertion.
Discussion
As the main mechanism of SAM, the Venturi theory has been
widely accepted. Venturi effect is created by high velocity ﬂow
caused by LVOT obstruction, and lifts the mitral valve toward the
septum. However, several studies demonstrated that SAM began
before the start of LV ejection in patients with HCM, which cannot
be explained by the Venturi theory [7]. Thus, structural changes
may play a primary role in the development of SAM in HCM
patients. Klues et al. analyzed the structure of mitral valves
pathologically in HCM patients and showed that 62 (66%) of
94 mitral valves had a constellation of structural malformations,
including increased leaﬂet area and elongation of the leaﬂets
[4]. Increases in mitral leaﬂet area and papillary muscle displace-
ment were also shown in patients with HCM using real-time 3-
dimensional echocardiography [6]. Levine et al. showed in normal
dogs that experimental anterior papillary muscle displacement
displaced mitral valve anteriorly, shifted the coaptation point initiation of a beta-blocker. (a) Left ventricular wall motion was normokinetic, and
r ﬂow imaging. Mitral regurgitation and left ventricular outﬂow obstruction almost
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residual leaﬂets that moved anteriorly [5]. In patients after mitral
valve plasty, an excess of valvular tissue and an undersized
annuloplasty were considered as major factors that contribute to
the development of SAM. A narrow aorto-mitral angle, a
hyperkinetic small ventricle, an IVS bulging, and an abnormal
conﬁguration of the anterior leaﬂet were also considered as
additional potential contributing factors [8]. In the present case,
elongation of mitral leaﬂet and hyperkinetic motion of left
ventricle, and IVS bulging due to narrow aorto-mitral angle
possibly play important roles in the development of SAM. Henein
et al. reported that in 80% of the patients with exertional dyspnea
and negative exercise test, SAM of the mitral valve and high
velocity ﬂow in the LVOT appeared during dobutamine stress
echocardiography, which were associated with basal septal
hypertrophy [9]. In contrast, the present patient did not have
any obvious triggers which cause hyperkinetic LV motion.
Although there are several previous reports regarding SAM of
the mitral valve without LV hypertrophy [10,11], the present case
is rare, because the attenuation of SAM by oral beta-blocker
therapy was dramatic, and severe MR and LVOT obstruction
completely disappeared. Once severe MR occurred, LV hyperkinet-
ic motion might be enhanced, leading to a vicious circle that
progressively exacerbated SAM, LVOT obstruction, and MR. Beta-
blocker therapy might terminate the vicious circle, eliminating
SAM, LVOT obstruction, and MR. Further studies are necessary to
clarify the precise mechanism of SAM in the absence of LV
hypertrophy.
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